TITLE

Estimated pre-morbid IQ effects on cognitive and functional outcomes in Alzheimer disease: a longitudinal study in a treated cohort

AUTHOR(S)
Starr, John M.; Lonie, Jane
PUB. DATE
January 2008
SOURCE
BMC Psychiatry;2008, Vol. 8, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cognitive reserve is thought to influence the degree of neuropathology needed for diagnosis of Alzheimer disease (AD). Cognitive reserve can be operationally defined as the hypothesized capacity of the mature adult brain to sustain the effects of disease or injury without manifesting clinical symptoms of AD, but sufficient to cause clinical dementia in an individual possessing less cognitive reserve. Its effect on the subsequent course of AD is less clear. Premorbid IQ is a useful measure of cognitive reserve. Methods: We studied 659 consecutive patients with AD at a tertiary referral memory clinic. Patients were assessed on six cognitive tests at baseline. Activities of Daily Living (ADL) were measured on the Instrumental Activities of Daily Living (IADL) scale and Physical Self-Maintenance Scale (PSMS). The National Adult Reading Test (NART) was used to estimate pre-morbid IQ. Patients were followed up after starting a cholinesterase inhibitor over 78 weeks. Mixed general linear models estimated the effects of NART on cognition and ADL. Results: Three hundred and fifty-five patients had NART scored with a mean estimated premorbid IQ of 104.7 (standard deviation 18.5). NART increased overall cognitive ability by 2.7% for every 10 IQ points (p < .001). There was a trend for an effect on the change in cognition over time (p = .065) with higher NART associated with improvement of cognitive ability over time. After adjusting for age and sex, a 10 point increase in NART was associated with an improvement of 2% in ADL scores, but this effect was explained by NART's influence on contemporaneous cognitive ability. Conclusion: Our data support the hypothesis that cognitive reserve continues to have a limited influence on cognition after AD has been diagnosed and thus, indirectly, has an impact on ADL.
ACCESSION #
35702781

 

Related Articles

  • Memantine in moderate to severe Alzheimer's disease: an observational post-marketing study. Rainer, Michael; Wuschitz, A.; Jagsch, C.; Erb, C.; Chirikdjian, J.-J.; Mucke, H. // Journal of Neural Transmission;Aug2011, Vol. 118 Issue 8, p1255 

    Memantine is an N-methyl- d-aspartate (NMDA) receptor antagonist, approved for the treatment of moderate to severe Alzheimer's disease (AD). We conducted a 4-month observational, post-marketing, Austrian study of memantine in 377 outpatients with moderate to severe AD. In this 'real-life'...

  • Specific cognitive domains and depressive symptoms as predictors of activities of daily living in older adults with heterogeneous cognitive background. Jardim de Paula, Jonas; Satler Diniz, Breno; Aparecida Bicalho, Maria; Albuquerque, Maicon; Nicolato, Rodrigo; Nunes de Moraes, Edgar; Romano-Silva, Marco Aurélio; Fernandes Malloy-Diniz, Leandro // Frontiers in Aging Neuroscience;Jul2015, following p27 

    Cognitive functioning influences activities of daily living (ADL). However, studies reporting the association between ADL and neuropsychological performance show inconsistent results regarding what specific cognitive domains are related to each specific functional domains. Additionally, whether...

  • Adaptation to Turkish Community and Reliability-Validity of ADCS-ADL Scale. İNCE, Aysun; MAVİOĞLU, Hatice; ESER, Erhan // Journal of Neurological Sciences;2011, Vol. 28 Issue 1, p4 

    No abstract available.

  • The Impact of Caregiver Executive Skills on Reports of Patient Functioning. Dassel, Kara Bottiggi; Schmitt, Frederick A. // Gerontologist;Dec2008, Vol. 48 Issue 6, p781 

    Purpose: The initial diagnosis and treatment of cognitive disorders such as mild cognitive impairment and Alzheimer's disease is highly dependent on caregiver reports of patient performance of activities of daily living (ADLs). However, these reports may not always be reliable. We investigated...

  • A INTERVENÇÃO TERAPÊUTICA OCUPACIONAL NAS ATIVIDADES DE VIDA DE PACIENTES PORTADORES DA DOENÇA DE ALZHEIMER. Mota, Wecsley Guilherme; De Moura, Roberta Míriam Barbosa; De Moura, Geraldo Jorge Barbosa // Scire Salutis;abr-set2012, Vol. 2 Issue 2, p56 

    Alzheimer's disease (AD) presents clinically several signs like memory disorders, difficulty with attention and concentration, visuospatial changes, inability to perform calculations, planning and judgment. In patients affected by AD, there is a decline in functional performance, starting with...

  • Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease. Wattmo, Carina; Londos, Elisabet; Minthon, Lennart // BMC Neurology;2014, Vol. 14 Issue 1, p1 

    Background A varying response to cholinesterase inhibitor (ChEI) treatment has been reported among patients with Alzheimer's disease (AD). Whether the individual-specific response, specific ChEI agent or dose affects mortality is unclear. We aimed to examine the relationship between the 6-month...

  • The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It? Hall, James R.; Hoa T. Vo; Johnson, LeighA.; Barber, Robert C.; O'Bryant, S. E. // International Journal of Alzheimer's Disease;2011, Vol. 2011, p1 

    Objectives. To investigate the link between neurocognitive measures and various aspects of daily living (ADL and IADL) in women and men with mild Alzheimer's disease (AD). Methods. Participants were 202 AD patients (91 male, 111 female) with CDR global scores of ≤1. ADLs and IADLs ratings...

  • Functional evaluation distinguishes MCI patients from healthy elderly people - The ADCS/MCI/ADL scale. PEDROSA, H.; DE SA, A.; GUERREIRO, M.; MAROCO, J.; SIMOES, M. R.; GALASKO, D.; DE MENDONCA, A. // Journal of Nutrition, Health & Aging;Aug2010, Vol. 14 Issue 8, p703 

    Patients with MCI may present minor impairments in activities of daily living (ADL). The main objective of this work was to evaluate the ability of two versions of the Alzheimer's Disease Cooperative Study / Activities of Daily Living scale adapted for MCI patients (ADCS/MCI/ADL18 and...

  • Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology. Sacco, Guillaume; Joumier, Véronique; Darmon, Nelly; Dechamps, Arnaud; Derreumaux, Alexandre; Ji-Hyun Lee; Piano, Julie; Bordone, Nathalie; Konig, Alexandra; Teboul, Bernard; David, Renaud; Guerin, Olivier; Bremond, François; Robert, Philippe // Clinical Interventions in Aging;2012 Part 2, Vol. 7, p539 

    Background: One of the key clinical features of Alzheimer's disease (AD) is impairment in daily functioning. Patients with mild cognitive impairment (MCI) also commonly have mild problems performing complex tasks. Information and communication technology (ICT), particularly techniques involving...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics